Trial intelligence / Profile preview

Dexmedetomidine Adjuvant in TAP Block for Cesarean Analgesia

NCT05342844Completed

Sponsor
Mansoura University
Start
May 2022
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Mansoura University. Primary endpoint: Time of the first postoperative analgesic requirement at 24 hours. Started May 2022; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05342844.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05342844.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call